Showing results (111-120 of 285) with videos related to
Sort By:
Pageof 29
Gastroenterology|December 14, 2005
Liver gene expression signature of mild fibrosis in patients with chronic hepatitis CTarik Asselah, Ivan Bièche, Ingrid Laurendeau, et al.Journal of Hepatology|April 12, 2002
Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriersMichelle Martinot-Peignoux, Nathalie Boyer, Magalie Colombat, et al.Hepatology (Baltimore, Md.)|August 30, 2008
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis BPatrick Marcellin, Ting-Tsung Chang, Seng G Lee Lim, et al.Hepatology (Baltimore, Md.)|August 30, 2008
Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissueTarik Asselah, Ivan Bièche, Ingrid Laurendeau, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2010
Metabolic disorders associated with chronic hepatitis C: impact of genotype and ethnicityThomas Sersté, Marcel Nkuize, Rami Moucari, et al.Antiviral Therapy|January 24, 2012
Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003-2007)Marc Bourlière, Denis Ouzan, Michel Rosenheim, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2008
Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failureFabien Zoulim, Parviz Parvaz, Patrick Marcellin, et al.Journal of Hepatology|February 2, 2013
Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patientsMichelle Martinot-Peignoux, Roberto Carvalho-Filho, Martine Lapalus, et al.Hepatology (Baltimore, Md.)|February 10, 2004
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient dataCalogero Cammà, Danilo Di Bona, Filippo Schepis, et al.Plos One|April 7, 2015
IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis CEmilie Estrabaud, Kevin Appourchaux, Ivan Bièche, et al.Pageof 29